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Abstract 
There is a need for brief screening instruments for autistic spectrum disorders (ASD) that can be used 
by frontline healthcare professionals to aid in the decision as to whether an individual should be 
referred for a full diagnostic assessment. In this study we evaluated the ability of a short form of the 
Autism Spectrum Quotient (AQ) questionnaire, the 10 item AQ-10, to correctly classify individuals as 
having or not having ASD. In a sample of 149 individuals with ASD and 134 controls without an 
ASD diagnosis, we found that the full AQ (AQ-50) abridged AQ (AQ-S) and AQ-10 all performed 
well as a screen for ASD. ROC analysis indicated that sensitivity, specificity and area under the curve 
were very similar at suggested cut-off’s for ASD across measures, with little difference in 
performance between the AQ-10 and full AQ-50. Results indicate the potential usefulness of the AQ- 
10 as a brief screen for ASD. 
 
Keywords: Autism; AQ; ASD; Screening; ROC analysis. 
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Introduction 
In a recent study, Allison, Auyeung and Baron-Cohen (2012) argued for the importance of the 
availability of a brief screen for autism spectrum disorders (ASD) that can be used by frontline health 
professionals as a means to identify individuals who should be referred for full diagnostic assessment. 
The Adult Autism Spectrum Quotient (AQ; Baron-Cohen, Wheelright, Skinner, Martin & Clubley, 
2001) was developed for the assessment of autistic traits in adults with normal intellectual 
functioning. It comprises 5 subscales measuring key traits thought to be important dimensions of 
ASD: social interaction, communication, attention to detail, attention switching and imagination. 
These dimensions were clinically derived based on the triad of impairment (Baron-Cohen et al., 
2001). It has undergone extensive psychometric development and evaluation, with the majority of 
studies supporting its validity in both individuals with and without a clinical diagnosis of ASD (e.g. 
see Wheelright, Auyeung, Allison & Baron-Cohen, 2010). 
An abbreviated version of the AQ, the AQ-10, has been developed in an attempt to meet the 
need for a brief screen for ASD (Allison et al.2012). Allison et al.(2012), in a sample of 449 adults 
with an ASD diagnosis and 838 controls randomly split into calibration (ASD=224; Control=419) and 
validation (ASD=225; Control=419) samples, selected the 2 items from each of the five subscales of 
the full AQ with the greatest discriminatory power (calibration sample). Table 1 shows the items 
included in the AQ-10 and the original item numbers from the AQ-50. 
(Insert Table 1 about here) 
The authors then used ROC analyses to test the discriminative power of the 10 selected items 
in the validation sample. They found that using a cut-point of 6, the 10 selected items yielded a 
sensitivity of 0.88, specificity of 0.91 and a positive predictive value of 0.85. This supported the 
utility of the 10 item form of the AQ as a “rapid screener” (p.208) for ASD to serve as a guide for 
further referral and evaluation. However, the authors pointed out that replications, particularly in 
samples in which participants’ diagnoses of ASD could be independently confirmed, would be 
important to assess the generalisability of this result. 
Therefore, the aim of the present study was to assess the ability of the AQ-10 to discriminate 
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between individuals with and without a confirmed diagnosis of ASD. For comparison, we also 
evaluate the full AQ (AQ-50) and the AQ short form (AQ-S; Hoekstra et al., 2011) to assess the 
extent to which important information is lost in the briefer measures. 
 
Method 
Ethics 
Ethical approval for the study was obtained, as applicable, from the local National Health 
Service ethics committee and Caldicott Guardians, and the research ethics committee at the first and 
sixth author’s home institutions. 
 
Participants and Measures 
All participants completed the 50 item AQ (Baron-Cohen et al., 2001). In line with Allison et 
al. (2012) and the majority of applications of the instrument, we scored the AQ dichotomously. For 
the current analysis, we included only those participants who had complete data on the AQ. 
 
ASD Sample 
We used archival data that have been analysed and described in detail in previous 
publications (Burnett & Jellema, 2012; Kuenssberg, Murray, Booth & McKenzie, 2012). The original 
data were collected from three sources: A Regional ASD Consultancy Service (RASDCS), a clinical 
psychology service in Scotland and disability services at universities in the North East of England 
where a prior diagnosis of AS or high-functioning autism was available. We note that there is debate 
about the diagnosis of ‘high- functioning autism’ (see Blacher Kraemer, & Schalow, 2006), but 
retained this term as this was the diagnostic term used by the independently diagnosing clinicians. 
In all instances, diagnosis was made with reference to the Diagnostic and Statistical Manual 
of Mental Disorders 4th Edition (American Psychiatric Association: DSM-IV-TR, 2000) by trained 
clinicians. In the case of RASDCS and the clinical psychology service, the diagnostic process 
included a clinical interview, informant interview (where possible) to obtain additional a 
developmental history and history of neuropsychological testing. The Adult Asperger Assessment 
5 
 
(Baron-Cohen et al., 2005) was administered routinely, but was not part of clinical diagnosis. 
The ASD sample for the current study was drawn from 3 independent sources (n=173). In the 
current study, we include only those individuals who had complete data for the AQ-50 in order to 
allow for comparisons across the full AQ-50, AQ-S and AQ-10. Data were anonymised prior to 
receipt and so the specific demographic characteristics of the sample are unknown. However, sample 
demographics from the larger samples from which the current complete cases were collated is 
available (see also Burnett & Jellema, 2012; Kuenssberg et al., 2012). The RASDCS sample 
comprised 140 individuals (102 males, 38 females) with a mean age at diagnosis of 33 (Range=17 to 
75); the clinical psychology sample comprised 13 individuals (10 male, 3 female) with a mean age at 
diagnosis of 34 (Range=19 to 47); finally the university sample comprised 20 individuals (15 male, 5 
female) with a mean age of 21 (SD=6.1). The final ASD sample used in the current analyses consisted 
of 149 individuals. 
 
Non-ASD Sample 
Non-ASD participants were recruited online and from a large university community and 
online social media. Participants completed an electronic version of the full AQ and also a number of 
basic demographic questions. Of the total number who began the online questionnaire (n=170), a final 
sample of 134 individuals (34 males, 100 females; mean age=29.6, range = 17 to 65) who had 
complete AQ data were used in the current study. All participants were free from clinical diagnosis of 
ASD. 
 
Statistical Method 
We used ROC analysis to evaluate the discriminative power of the AQ-10 (Allison et al., 
2012). For comparison, we also evaluated the full AQ (AQ-50; Baron-Cohen et al., 2001), and the AQ 
short form based on item selections by Hoekstra et al. (2011) (AQ-S). The suggested optimal cutpoint 
for the AQ-10 and AQ-50 based on previous ROC analyses are 6 for the AQ-10 and 26 or 32 for 
the AQ-50. Optimal cut-points for the AQ-S dichotomously scored have yet to be established but 
Hoekstra et al. (2011) suggest cut-points of above 65 or 70 or greater when the instrument is scored 
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on a four-point scale. 
We evaluated the discriminative power of each measure based on sensitivity, specificity and 
area under the curve (AUC). AUC provides global measure of the predictive validity of the measure. 
Values above 0.90 are generally considered to indicate excellent validity. Sensitivity and specificity 
were computed for all whole number thresholds within each inventory using the ‘pROC’ package 
(Robin et al., 2011) in R 2.13.0. Confidence intervals were computed using the default 2000 stratified 
bootstrap replicates. 
 
Results 
Table 2 displays the AUC for the AQ, AQ-S and AQ-10, and the sensitivity and specificity of 
the suggested cut-points. The AUC for all three measures is >90%, suggesting that the shortened 
versions of the AQ retain the predictive validity of the full 50 item inventory. 
  
(Insert Table 2 about here) 
 
In the case of both the AQ and AQ-10, the suggested cut-points from previous studies 
performed reasonably well. For the AQ, the cut point of 26 would be preferred to a cut point of 32 
within the current sample. For the AQ-S, no cut-points have been published for the binary scoring. 
Here we present results from all cut-points where the median values from the bootstrapped analysis 
were greater than 70%. Based on both medians and confidence intervals, a cut-point of 16 appears to 
provide the best balance of sensitivity and specificity. 
 
Discussion 
We found that the AQ-50, and AQ-10 performed well at discriminating between individuals 
with and without a clinical diagnosis of ASD at the cut-points suggested by the test developers. In 
addition, based on our analyses we tentatively suggest a cut-point of 16, based on a dichotomous 
scoring method, if the AQ-S is to be used as a screening instrument for ASD. There was little loss of 
discriminative power in AQ-10 compared with the AQ-S and AQ-50. This suggests that, for frontline 
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professionals for whom the longer measures would be too time consuming to administer, the much 
briefer AQ-10 would be an appropriate alternative. A score above the 6 on the AQ-10 would be 
indicative to the clinician of the need to undertake a full diagnostic assessment with the individual, 
which incorporated all of the recommended components (National Institute for Health and Clinical 
Excellence, 2012) 
It is important to point out the potential limitations of our study. Our sample was restricted to 
adults of average intelligence as the AQ is designed for use in this group only. Conclusions on its 
discriminative power are, therefore, not necessarily applicable to the large number of individuals with 
ASD and low intellectual functioning (Matson & Shoemaker, 2009). 
The non-ASD sample for the present study was a mix of participants recruited online and 
through the University community; therefore, it may not be representative of the general population as 
a whole. More importantly, however, non-ASD sample was comprised of individuals who had not 
previously been referred for clinical assessment and, therefore, we could not evaluate how well the 
screening instrument performed in a clinical or referred setting. It is likely that the discriminative 
power observed when applied to a diagnosed versus a general clinical sample or a sample at risk of 
ASD would be lower than that observed in the present study. 
The discriminative power of the instrument will also depend on other characteristics of the 
ASD and comparison sample. For example, in the present study we had a high male:female ratio in 
the ASD group and the opposite in the non-ASD group. Given that it is thought that ASD traits tend to 
manifest more often and to a greater extent in males than in females (e.g. see Mandy et al., 2012), it is 
likely that the discriminative power of the instrument would be lower if a more heavily male non- 
ASD sample were used. Thus, future studies should aim to assess the discriminative power of the 
instrument across other relevant comparison and ASD sample compositions with respect to sex and 
other characteristics. 
It also is possible that sex differences in ASD could result in the AQ being sex biased, 
meaning that it does not have equivalent measurement properties in both sexes. A possible 
consequence of this could be a systematic over-estimation of the scores of one sex relative to the other 
sex. Here, measurement invariance was not assessed due to insufficient sample size and neither has it 
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been assessed in previous studies. Measurement invariance procedures provide formal tests of the 
equivalence of a given instrument across groups (Wicherts & Dolan, 2010) and the results of the 
current study should, therefore, be considered in light of the lack of studies assessing measurement 
invariance of the AQ instruments. Such studies remain practically difficult given the generally large 
samples required to conduct invariance analyses and the comparative scarcity of females with an ASD 
diagnosis. However, future research should seek to test whether the AQ instruments display 
measurement invariance. 
Finally, did not examine the child and adolescent versions of the AQ and their briefer 
counterparts in the present study. It, therefore, remains an important future direction for these two 
measures to be evaluated in a sample independent of the initial calibration and validation samples of 
Allison et al.(2012). 
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Table 1: 
Items of the AQ-10 and Original AQ-50 item numbers 
Scale Item Original Item 
Number from AQ-50 
Attention to Detail I often notice small sounds when others do not. 5 
 I usually concentrate more on the whole picture, rather than the small details. 28 
Attention Switching I find it easy to do more than once thing at once. 32 
 If there is an interruption, I can switch back to what I was doing very quickly. 37 
Communication I find it easy to ‘read between the lines’ when someone is talking to me. 27 
 I know how to tell if someone listening to me is getting bored. 31 
Imagination When I’m reading a story I find it difficult to work out the characters intentions. 20 
 I like to cllect information about categoris of things (e.g. types of car, types of bird, types of train, types of 
plant, etc) 
41 
Social I find it easy to work out what someone is thinking or feeling just by looking at their face. 36 
 I find it difficult to work out people’s intentions. 45 
 
Adapted from Allison, et al. (2012, Table 2, page 207). 
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Table 2: 
Area Under the Curve (AUC), Sensitivity, Specificity for the AQ, AQ-10 and AQ-S and suggested cut points. 
 AUC Sensitivity 95% CI Specificity 95% CI 
AQ-50 91.38%     
Cut-point 26  87.92% 75.17% to 96.64% 79.85% 68.66% to 89.55% 
Cut-point 32  69.80% 56.38% to 83.22% 91.04% 82.09% to 98.51% 
AQ-10 90.27%     
Cut-point 6  79.87% 69.13% to 90.60% 87.31% 76.87% to 95.52% 
AQ-S 91.06%     
Cut-point 14  91.95% 83.89% to 98.66% 73.13% 56.72% to 84.33% 
Cut-point 15  89.26% 81.21% to 97.99% 76.87% 60.45% to 88.81% 
Cut-point 16  84.56% 74.50% to 93.96% 82.84% 68.66% to 93.28% 
Cut-point 17  79.19% 65.77% to 89.86% 85.08% 72.39% to 94.78% 
Cut-point 18  71.14% 59.06% to 82.55% 88.81% 79.10% to 97.02% 
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